Your legacy can help bring an end to CMT. Learn how a planned gift can make an impact for generations to come.
Manitowoc, WI Cycle4CMT
09/16/2023 @ 9:00 am – 12:00 pm – Join us at the Manitowoc, Wisconsin Cycle4CMT Cycle4CMT is a volunteer-led national fundraising campaign for the CMTA. By participating in this year-round campaign, you will be joining thousands of others across the country who want to improve the lives of those living with CMT. Funds raised by the Cycle4CMT campaign fuel the CMTA’s mission to […]
CMTA Adds Drug Development Expert Martine Garnier to STAR Advisory Board
…CMT patients.” CMT is a progressive disorder of the peripheral nerves that causes people to lose the normal use of their feet and legs. Symptoms include foot deformity (very high…
Donate to CMTA
…challenges, it also reveals incredible strength, resilience, and hope. At CMTA, we are committed to empowering the entire CMT community to live their fullest lives while advancing research that will…
The CMTA Announces the Funding of a New Research Study for CMT2A
…CMT. Her father and mother, JD and Brenda Griffith, made a donation in Marah’s honor to the CMTA through the CMT Foundation to fund this important clinical research study. For…
Actio Biosciences Doses First Participant in Phase I Clinical Trial | Future Phase Ib Clinical Trial to Focus on CMT2C
…“This Phase I clinical trial is an important step forward for the CMT2C community and our CMTA-STAR Alliance Partner, Actio Biosciences,” said CMTA CEO Sue Bruhn, PhD. “CMT2C is a…
Exploring New Therapeutic Pathways for CMT1B: UPR Activation
…improve the symptoms of CMT1B. Dr. D’Antonio and his colleagues tested various compounds in CMT1B models to determine whether these could effectively activate the UPR pathways. The initial results are…
Craig Zeltsar Joins CMTA Board of Directors
…the CMT community for many years. In his spare time, Craig likes to ski, cook, bike and stay active outdoors. To learn more about getting involved with the CMTA, click…
Three Major Patient Advocacy Groups Focused on CMT Research Collaborating on FDA “Voice of the Patient” Report
This CMT Awareness Month, the Charcot-Marie-Tooth Association (CMTA) is proud to join the Muscular Dystrophy Association (MDA) as a sponsor of the Hereditary Neuropathy Foundation (HNF) who will be hosting…
David Coldiron Joins CMTA Board of Directors
Glenolden, PA, Nov. 4, 2019 — The Charcot-Marie-Tooth Association (CMTA), the national patient advocacy organization leading CMT research, today announced the appointment of David Coldiron to its Board of Directors….
CMTA Announces New Center of Excellence at Duke University Hospital
The Charcot-Marie-Tooth Association (CMTA), the world’s largest philanthropic funder of research aimed at bringing treatments to patients and improving the lives of those living with Charcot-Marie-Tooth disease (CMT), is thrilled…